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Abstract 
During development, in the central nervous system (CNS), oligodendrocyte progenitor cells 
(OPCs) migrate to axons and eventually become mature oligodendrocytes. Mature oligodendrocytes 
wrap around axons and produce myelin sheaths, which insulate the axons. Growth factors, specifically 
platelet derived growth factor (PDGF) and fibroblast growth factor (FGF), are released in the 
development of OPCs to promote congruent gene expression. PDGF is released to induce the 
proliferation of OPCs, and to promote their migration to axons. FGF induces OPC maturation into 
oligodendrocytes, and initiates axon myelination. OPCs act in a similar fashion following a spinal cord 
injury. PDGF and FGF are released as new OPCs develop, migrate to the injury site, and mature into 
oligodendrocytes in an attempt to repair damaged axons. We observed the same processes occurring in 
vitro with embryonic stem cells (ESCs) from our wild-type mouse model. Growth factors FGF and PDGF 
were added to the media to promote OPC morphology in mature ESCs by the activation of their 
respective growth factor receptors leading to the phospholipase C-gamma (PLCγ) pathway which results 
in the Ca2+ efflux from the endoplasmic reticulum (ER). In 1993, the Campagnoni lab discovered that the 
myelin basic protein (mbp) gene was part of a larger transcription complex called golli-mbp, whose 
products regulate store operated calcium channels on the ER membrane. We were able to better study 
the effects of golli-MBP through our M3 enhancer knockout (M3KO) mouse model where golli-MBP 
products were downregulated at the OPC stage of development. Deletion of the M3 enhancer resulted 
in the down regulation of both golli and MBP specific proteins in vivo. We generated WT and M3KO ES 
cell lines to investigate the potential influence of Golli-MBP in progenitor cell maturation. We found that 
the M3KO ES cells did not respond to FGF or PDGF to allow for proper cell adhesion and the 
differentiation into OPCs. These results suggest that deletion of the M3 enhancer reduces the 
expression of golli-MBP, which leads to the dysregulation of the signaling pathways necessary for the 
differentiation of ES cells into OPCs.  
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Introduction 
 Stem cells can be totipotent, pluripotent, multipotent, oligopotent, or unipotent depending on 
the tissue origin of the progenitor cell (Temple, 2012). Embryonic stem cells (ESCs) are pluripotent cells 
that are characterized by their capacity for self-renewal and their ability to generate all cell types of the 
ectoderm, mesoderm, and endoderm while in an undifferentiated state (Yu and Thomson, 2010). 
Because of these properties, ESCs are widely used in research due to their relatively unlimited supply, 
and their ability to differentiate into a plethora of cell types. The functions and processes of ESCs are 
regulated by multiple intracellular and extracellular agonists, including the release of growth factors, 
which induces a broad range of cell-type specific signaling events. In vitro, chemical inducers, such as 
these growth factors and chemokines, are added to the cell culture to promote proliferation, survival, 
and differentiation (Annerén, 2008).   
Growth factors interact with target receptors to induce specific cellular responses to stimuli. 
Examples of growth factors pertinent in ES studies include Leukemia inhibitory factor (LIF), epidermal 
growth factor (EGF), basic fibroblast growth factor (bFGF), and platelet-derived growth factor (PDGF). LIF 
is a cytokine that modulates the proliferation of ES cells and stimulates self-renewal processes through 
activation of the Janus kinase/ signal transducer and activator of transcription 3 (JAK/STAT3) and the 
extracellular regulated kinase 1/2 (ERK1/2) signaling pathway (Annerén, 2008). Activation of JAK, by the 
LIF receptor, induces the phosphorylation of the STAT3 transcription factor. Upon phosphorylation, 
STAT3 dimerizes and migrates into the nucleus where it binds to promotor regions of genes regulating 
self-renewal. In vitro, researchers utilize the activity of LIF to inhibit the differentiation of the ESCs. bFGF 
acts on a variety of FGF receptors, including FGFR4, which induces differentiation by the termination of 
the ES self-renewal program primarily through the activation of the ERK1/2 signaling pathway (Ying et 
al., 2008). These studies suggest that the ERK1/2 signaling cascade plays a role in the ESC’s commitment 
to a cell lineage. Upon binding bFGF, the receptor homo-dimerizes and cross-phosphorylates specific 
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tyrosine residues on the partnering monomer. This allows the Son of Sevenless (SOS) guanine nucleotide 
exchange factor to initiate the phosphorylation cascade by activating Ras and up-regulating receptor 
tyrosine kinase activity (Mebratu et al., 2009). 
Protein kinases give regulate very specific functions in the cell through the phosphorylation and 
activation of target kinases and proteins. ERK1/2 is a mitogen-activated protein kinase (MAP kinase) that 
regulates the growth and proliferation of many cell types (Fyffe-Maricich et al., 2011), including ESCs. 
ERK1/2 acts via the MAP kinase I signaling cascade that plays a major role in cell metabolism, adhesion, 
migration, survival, and differentiation. Extracellular stimuli, particularly growth factors, may interact 
with receptor tyrosine kinases to initiate two different signaling pathways. Growth factors can not only 
trigger the MAP Kinase cascade, but activate the phospholipase C-gamma (PLC-γ) pathway as well 
(Moenning et al., 2009). The PLC-γ pathway acts through store operated calcium channels (SOCCs) 
causing a Ca2+ efflux from the endoplasmic reticulum (ER) (Markova et al., 2010).  
The activation and roles of growth factors change depending on environment and cell type. The 
timing of growth factor receptor activation in ESCs are similar in the development and maturation of 
oligodendrocyte progenitor cells (OPCs) in the central nervous system (CNS). OPCs are glial cells in the 
central nervous system that are fated to become mature oligodendrocytes. Post-natally, in mice, PDGF 
release induces OPC proliferation and migration to axons (Zhu et al., 2014). FGF release induces their 
development into immature oligodendrocytes, and then further into myelinating oligodendrocytes 
(Fortin et al., 2005). FGF is also present when mature oligodendrocytes wrap around axons to promote 
the production of myelin sheaths (Furusho et al., 2012). This insulates the axons to promote maximal 
signal transduction for communication between neurons. The generation of myelin is most important 
early in life and steadily declines throughout maturity. Although myelin basic protein (MBP) is not as 
highly expressed throughout adult life, oligodendrocytes are stimulated to generate more myelin as a 
result of demyelination following traumatic injury (Zawadzka et al., 2010). Spinal cord injuries mirror 
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early developmental events, in that FGF and PDGF are released as OPCs are recruited to develop and 
migrate to the site of injury in an attempt to re-myelinate damaged axons.  
Spinal cord injuries trigger a cascade of intracellular and extracellular events that lead to 
changes in cell function and expression (D’Angelo, 2013). Currently, spinal cord injuries present a wide 
range of neuropathologies as well as limited functional recovery. Much damage is due to secondary 
processes that result from the sudden influx of cytokines, such as TNF-α and IL-1β, chemokines, and the 
inflammation that follows through microglia activation (Rivest, 2011). Although cytokines are important 
for recovery, their sustained increase can lead to neuronal death. Such pathologies may include glial 
scars due to astrocytic and microglia activation, dystrophic neurons, neuronal cell death, secondary axon 
damage, axon demyelination, and delayed Ca2+ influx (Oyinbo, 2011). Oligodendrocytes are particularly 
susceptible to cell death following a brain or spinal cord injury (Almad et al., 2011), and the replacement 
of these cells could support the remaining damaged axons through re-myelination that would help 
restore electrical conduction in the axons. 
Axons release neurotransmitters that influence oligodendrocytes at different stages in 
development through mediation of Ca2+-dependent pathways (Butt, 2006). The gene golli-mbp, 
discovered in 1993 by Campagnoni et al., is important for regulating Ca2+ signaling in OPCs and 
oligodendrocytes through depolarization. The down-regulation of golli-MBP could inhibit 
oligodendrocyte depolarization resulting in Ca2+ dysregulation. The M3 enhancer in oligodendrocytes is 
responsible for maximal expression of mbp and golli-mbp (Dib et al., 2011). MBP is required for 
oligodendrocytes and Schwann cells to effectively myelinate their axons, but it is more highly expressed 
in the CNS (Dib et al., 2010). Dib et al. (2010) observed that deletion of the M3 enhancer results in the 
down-regulation of classic mbp as well as golli- mbp splice variants in vivo. This may inhibit the ability of 
OPCs to properly interact with their various growth factors.  
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While primary injuries are often sudden and unexpected, secondary injury mechanisms can be 
studied and eventually treated (Oyinbo, 2011). One mode of treatment under investigation is to 
transplant oligodendrocyte-fated progenitor cells into the spinal cord at various stages of injury to 
induce re-myelination and promote functional recovery. To further understand golli-MBP interactions in 
vitro, a model of wild-type (WT) and M3 enhancer knockout (M3KO) ESCs were treated with various 
growth factors and compared at various time points. Since growth factors, specifically FGF and PDGF, 
play similar roles in the development of oligodendrocytes in the CNS and in the differentiation of ESCs to 
OPCs, the knockdown of golli-MBP may, in turn, cause an inhibition of growth factor receptor pathway 
signaling, due to Ca2+ efflux dysregulation.   
Methods 
C57/BL6 Mouse Embryonic Fibroblast (mEF) Culture Conditions 
The WT and M3KO C57/BL/6 mice were provided as gifts from the Peterson Lab at the Royal 
Victoria Hospital (McGill University). Three Cultures of both M3KO and C57/BL/6 mouse embryonic 
fibroblasts mEFs were grown in parallel. mEFs were provided by Nationwide Children’s Hospital. DMEM 
supplemented with 10% fetal bovine serum (FBS) and 100 U penicillin / 100 µg/ ml streptomycin were 
used to feed the mEF cultures. MEFs were quickly thawed in a 37°C water bath directly from liquid N2 
and suspended in the mEF media under a biosafety cabinet hood (~1x106 cells per 10 cm plate). The 
cells were plated on 10 cm surface modified culture dishes and incubated at 37°C and 5% CO2 until 
confluent. 
C57/BL6 mEF Feeder Layer Formation 
 0.25% gelatin plates act as a foundation for the C57/BL6 mEF feeder layer. Gelatin plates were 
created by dissolving 25 mg gelatin in 10 ml dIH2O in a 37°C water bath. Once it is completely dissolved, 
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the gelatin is sterilized using a 0.4 μm syringe filter. The gelatin was then coated onto cell culture plates 
with 10 ml per 10 cm plate overnight at 37°C.  
 The media from the mEF culture was aspirated and washed twice with Dulbecco’s phosphate- 
buffered saline (DPBS). Immediately after aspirating the DPBS, 4 ml of 0.25% Trypsin was added per 10 
cm plate. The plate was then incubated at 37°C until the mEFs lifted from the substratum. The mEFs 
were transferred into 10% FBS in DPBS with a disposable pipet and centrifuged for five minutes at 1000 
rpm and 25°C. The supernatant was gently aspirated, replaced with fresh mEF media, and triturated. The 
gelatin was aspirated, and the plates were rinsed twice with DPBS. The cells were plated with mEF 
media onto the gelatin coated plates. Once the mEFs were confluent, they were inactivated with 10 
µg/ml mitomycin C in mEF media and incubated at 37°C for three hours. After three hours, the 
mitomycin C was aspirated from the fibroblasts and washed three times with DPBS. The plates were 
then replaced with fresh mEF media and incubated overnight at 37°C and 5% CO2. 
Undifferentiated Embryonic Stem (ES) Cell Expansion 
C57/BL6 WT ES cells were purchased from American Type Culture Collection (ATCC). 
Undifferentiated M3KO ES cells were produced by the ES care facility in Nationwide Children’s 
Hospital’s. DMEM/F12 supplemented with 10% ES-FBS, 100 U penicillin/ 100 µg/ ml streptomycin, 1% 
non-essential amino acids, 2 mM Glutamine, 55 µM β-Mercaptoethanol, and 10 ng/ml LIF were used to 
feed the ES cultures. ES cells were quickly thawed in a 37°C water bath, directly from liquid N2. MEF 
media was aspirated from the feeder layer and washed twice with PBS. The ES cells were suspended in 
ES-LIF media (~1x106 cells / 10 cm plate) and transferred onto the feeder layer culture plates. The plates 
were incubated at 37°C and 5% CO2. The ES-LIF media was changed daily until the formation of large ES 
colonies. 
Feeder Layer mEF Removal 
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 After the formation of large ES colonies, media was aspirated from the cultures and the plates 
were washed twice with DPBS. 4 ml 0.25% trypsin was added per 10 cm plate and incubated at 37°C 
until the ES colonies lifted from the substratum. Once the colonies lifted, they were transferred using a 
disposable pipet with the tip cut off into 10% FBS in DPBS. The cells were centrifuged for 5 minutes at 
1000 rpm and 25°C. The ES colonies were gently re-suspended in the 10 ml ES-LIF media and poured 
onto 10 cm surface treated culture plates. The plates were incubated at 37°C and 5% CO2. The ES-LIF 
media was changed daily until large ES colonies re-formed.  
Embryoid Body (EB) Formation and Culturing 
EBs are non-adherent, 3-dimentional ES cell spheres that are used for differentiation into neuronal 
lineages. To establish the formation of EBs, large ES colonies were left to re-form on the feeder layer. 4 
ml 0.25% Trypsin was added per 10 cm plate and the cells incubated at 37°C until the ES colonies lifted 
from the substratum. Once the colonies lifted, they were transferred using a disposable pipet with the 
tip cut off into 10% FBS in DPBS. The tips of the pipets were cut off to provide more surface area for the 
colonies to pass through with little disruption. The cells were centrifuged for 5 minutes at 1000 rpm and 
25°C. The ES colonies were then gently re-suspended in serum-free, ES-knockout serum replacement 
(KSR) media (DMEM/F12, 20% KSR (Invitrogen), 100 U penicillin/ 100 µg/ml streptomycin, 1% non-
essential amino acids, 2 mM Glutamine, 55 µM β-Mercaptoethanol) and poured onto low-adhesion petri 
dishes. The petri dishes were incubated at 37°C and 5% CO2. The media was changed daily. 
To change the suspension culture, the EBs were transferred to a 15 ml tube using a plastic pipet with 
the tip cut off. The EBs were allowed to gravity settle. The media was gently aspirated and EBs were re-
suspended in fresh media by gently inverting the tube. The re-suspended EBs were poured into a fresh 
petri dish. From day four to seven, 0.2 µM of retinoic acid was added to the petri dishes to induce neural 
crest formation as well as the formation of the neuroectoderm. From day five to seven, 1µM of 
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purmorphamine, a sonic hedgehog (SHH) inducer, was added to further induce neural progenitor 
formation. On day six, KSR was removed and the plates were supplemented with 1% N2 (Invitrogen), 0.2 
µM Retinoic Acid, and 1µM purmorphamine. 
Adherent OPC Culture 
 On day seven, surface modified culture dishes were pre-coated with 0.01% polyornithine and 5 
µg/ml laminin in DPBS. The dishes were incubated overnight at 4°C. The 0.01% polyornithine and 5 
µg/ml laminin in DPBS was then aspirated and washed twice with DPBS. The EBs were transferred to a 
15 ml tube and allowed to gravity settle. The supernatant was gently aspirated. The EBs were re-
suspended in 1% N2 media (minus RA and purmorphamine) and supplemented with 10 ng/ml basic 
fibroblast growth factor (bFGF). The media was changed daily as the EBs were allowed to gravity settle, 
and become adherent. After four days, the N2/FGF media was further supplemented with 10 ng/ml 
epidermal growth factor (EGF). Treatment with FGF/EGF for prolonged time induced the EBs to 
differentiate and develop oligodendrocyte precursor cell (OPC) morphology. Four days later, the FGF 
and EGF were removed and the N2 media was supplemented with 10 ng/ml PDGF for three days. 
RNA Extraction 
 RNA was extracted at three different phases of ES differentiation into OPCs. RNA was extracted 
from the control group after a large embryonic body formation, then from the EBs treated with FGF, and 
the EBs treated with PDGF. Embryoid body suspension cultures, or adherent EB cultures, were lysed 
with 500 mL TRIzol® reagent (Invitrogen), and ground using sterile, disposable pestles. The TRIzol® 
suspensions were extracted with 200 mL of chloroform, and the resulting aqueous phases transferred to 
RNEasy (Qiagen) columns. The RNA was purified as per the manufacturer’s protocol, and quantitated. 
Reverse Transcription Reaction 
9 
 
 10 mL of RNA (~10 mg) was combined with 2.5 U of DNAse (Roche), and incubated for 30 mins 
at 37°C to remove any contaminating gDNA. 5 U of Moloney’s Murine Leukemia Virus (M-MLV) 
(Invitrogen) reverse transcriptase, 1 mM dithiothreitol (DTT), 0.1 mM anchored oligo-dT primer 
(Invitrogen), and 10mM nucleotides were combined with the reaction. The RT was allowed to incubate 
overnight at 37°C, and the resulting cDNA purified using QIAquick® (Qiagen) columns, as per 
manufacturer’s protocol. The purified cDNA was quantitated by spectrophotometry. 
Quantitative Real-Time PCR 
  50 mL of 15 ng/μL cDNA was combined with 100 μL RT2 CYBR green (Qiagen) and 50 μL H2O to 
produce a master mix for 10 reactions, in triplicate, for each cell culture condition. 20 μL (75 ng cDNA) 
of the master mix was added to the plate wells containing primers for the eight signature target genes 
(Nanog, Stat3, Gli2, Pax6, Hspg4, Olig2, mbp, gfap) and two endogenous controls (gapdh and actb) in a 
pre-made signature gene PCR 96-well plate (Qiagen). The PCR reactions were run through forty cycles, 
and the threshold cycles (CT) values for each reaction determined using the supplied qRT-PCR software 
(ABI). 
Each gene product, relative quantity was compared using the ΔΔCT method. Briefly, the CT 
values for each gene product were, first, set relative to the endogenous control by: 
 
ΔCT = CT, gene - CT, control          (1) 
 
The relative ΔCT values were then compared between the FGF-treated and the untreated EB 
samples for each ES cell origin (wild type and M3KO): 
 
ΔΔCT, gene = 2- (ΔCT, FGF – ΔCT, EB)          (2) 
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All triplicate gene values were compared using the above equation (2), and the average ΔΔCT 
value computed. To determine significance between the wild-type and M3KO groups, student t-Tests 
were performed for each gene’s replicate ΔΔCT values. 
Results 
1. Cell Culture 
a) Embryonic stem cell cultures 
There were no large morphological differences observed between the WT and M3KO 
cultures at the adherent embryonic stem cell culture stage. Both WT and M3KO ESCs grew 
well in vitro. The WT ESCs grew into tight, compact balls whereas the M3KO ESCs were not 
as compact or confluent. Both cultures quickly adhered to the mEF monolayer and 
proliferated until they were approximately 80% confluent. 
b) Non-adherent embryoid body cultures 
After the formation of large ES colonies, the mEF feeder layer was removed and the 
large ES colonies were left to re-form. Both the WT and M3KO cultures grew into EBs in the 
same timeframe. Both cultures were then trypsinzed and transferred into KSR media where 
they successfully expanded into large, non-adherent EBs (Figure 1). The WT and M3KO 
cultures were then treated with retinoic acid and purmorphamine to sequentially induce 
their transition into neuronal progenitor cells. Upon the introduction to these supplements, 
we began to observe that some WT cells were prematurely adhering to the petri dish. The 
M3KO cultures did not experience this adhesion phenomenon.  
c) Adherent embryoid body cultures supplemented with FGF 
The WT and M3KO cultures were transferred to 0.01% polyornithine/laminin plates, and 
re-suspended in N2 media supplemented with 10 ng/ml bFGF to induce OPC differentiation. 
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The EBs were allowed to gravity settle and become adherent. The WT EBs immediately 
began to adhere, however the M3KO EBs failed to settle. By the eighth day, when both bFGF 
and EGF were to be replaced with PDGF, we observed a large amount of differentiation in 
WT EBs. We noticed the cells began migrating away from the EB as they differentiated, 
leaving room for more cells to differentiate from the edges of the EB (Figure 1). However, 
the majority of M3KO EBs were still non-adherent and undifferentiated. 
d) Embryoid body cultures treated with PDGF 
The growth factors FGF and EGF were removed and replaced with 10 µg/ml PDGF. The 
WT cultures were completely adherent and differentiated robustly. The WT EBs generated 
OPCs that consisted of cells with two or three processes extending from opposing sides of 
the cell body (Figure 1). Even with the polyornithine-laminin treated plates and treatment 
with PDGF, the majority of M3KO EBs still failed to adhere. The EBs that did adhere failed to 
differentiate and migrate from the EBs.  
2. Q-RT PCR 
The ΔΔCT compared FGF treated WT EBs with untreated WT EBs and FGF treated M3KO 
EBs with untreated M3KO EBs. The ES marker, Nanog, was significantly up-regulated in the FGF 
treated WT EBs compared to the untreated EBs with a ΔΔCT value of 2.1 (Figure 2). The glial 
marker Olig2, normally expressed in mature oligodendrocytes, was significantly up-regulated in 
the FGF treated WT EBs compared to the untreated EBs. Glial markers NG2 and MBP had ΔΔCT 
values of 0.3 and 0.5 respectively, thus were significantly down-regulated in the FGF treated 
M3KO EBs compared to the untreated M3KO EBs. A student t-test examination indicated a 
significant level of variance between the WT and M3KO EBs for glial markers Pax6 (p-value= 
0.04) and NG2 (p-value= 0.01). The ES marker Gli2 was non-detectable for both WT and M3KO 
EBs. The glia marker MBP in the WT EBs was also non-detectable. 
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Figure 1 
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Figure 1. M3KO EBs do not differentiate in response to the growth factors FGF and PDGF. WT and 
M3KO EBs were plated onto poly-L-ornithine and laminin treated plates. In the untreated controls, the 
WT EBs grew larger and more robust than M3KO EBs. Upon treatment with 10 ng/µl FGF for three days, 
WT EBs became adherent, and the differentiating cells migrated from the EB. Treatment with 10 ng/µl 
PDGF for three days increased WT differentiation and promoted an OPC phenotype. The growth factor 
supplementation with FGF and PDGF seemed to have no effect on the M3KO EBs, in that there was no 
observed adhesion nor differentiation. 
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Figure 2 
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Figure 2. Glia marker gene products were significantly down-regulated in M3KO EBs. 75ng of RT 
product from the WT and M3KO extractions were analyzed by qRT. The ΔΔCT levels of significance were 
0.5 ≥ ΔΔCT ≥ 2.0. Red indicates the significant up-regulation of gene markers for ΔΔCT, green represents 
the significant down-regulation of gene markers for ΔΔCT, black indicates the non-significant ΔΔCT 
values of WT EBs and grey indicates the non-significant ΔΔCT values of M3KO EBs. The asterisks 
represent a level of significance at p ≤ 0.05 for the student t-test examination. The WT ES gene marker, 
Nanog, was significantly upregulated at ΔΔCT= 2.1 in response to prolonged FGF treatment relative to 
no treatment in contrast to the ES gene markers STAT3 and Gli2 (A). The WT Glial gene marker, Olig2, 
was significantly upregulated at ΔΔCT= 2.6 (B). The ΔΔCT values of the M3KO ES gene markers, in 
response to prolonged FGF treatment relative to no treatment, were not significant (C). The M3KO Glial 
gene markers for NG2 and MBP were significantly downregulated at ΔΔCT= 0.3 and 0.5 respectively (D).  
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Discussion  
 Previous studies have shown that implantation of OPCs into injured spinal cords could generate 
mature oligodendrocytes to restore axon myelination and efficient electrical conductance between 
synapses (Thuret et al., 2005). Initially, we planned to implant fated pre-OPC WT and M3KO ESCs into 
mice with spinal cord injuries. The fated pre-OPCs are plastic, late-stage ESCs that would likely survive 
and adapt to their change in environment by responding to growth factors released from the injury site. 
We hypothesized that the pre-OPCs would become OPCs and then mature into myelinating 
oligodendrocytes. Further, since many differentiation processes are Ca2+ dependent and golli-MBP is 
known to modulate many intracellular events in OPCs through store-operated and voltage-gated 
calcium channels (VOCC) (Chew et at., 2010), we intended to use the M3KO model to further investigate 
the role of golli-MBP in Ca2+ dysregulation and its effects on remyelination post-injury.  
  In adherent EB cultures, bFGF was added to promote OPC morphology and the addition of PDGF 
further induced the EBs to differentiate and commit to the oligodendrocyte cell lineage. While the WT 
EBs adhered and differentiated robustly during cell culture, we failed to replicate these results in the 
M3KO EB cultures even with the addition of the various growth factors (Figure 1). These results suggest 
that the knockdown of golli-MBP may have resulted in the dysregulation of voltage-gated and SOCCs of 
the EBs that lead to the inhibition of growth factor signaling pathways. It is still unknown where this Ca2+ 
dysregulation stems from. One possibility is that the efflux of Ca2+ activates calmodulin kinase (CamK), 
which in turn is known to phosphorylate Erk1/2 (Hudmon and Schulman, 2002). Additionally, Ca2+ can 
also actuate protein kinase C (PKC), which acts upstream of Erk1/2 by stimulating Ras and thus initiating 
the MAP kinase signaling cascade. The additive effects of these two kinases converging at Erk1/2 may 
cause the over-activation of down-stream effectors, particularly transcription factors. 
The Erk1/2 MAP kinase signaling cascade is critical for the termination of the ES cell self-renewal 
program to induce differentiation (Ying et al., 2008). In a process termed feedback inhibition, Erk1/2 can 
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inhibit its own phosphorylation by binding to its upstream effectors, MEK1/2, Grb, and SOS. Erk1/2 can 
bind to MEK1/2, producing a barrier that physically inhibits the binding and phosphorylation of the 
entire Raf family (Dhillon et al., 2007). Binding to Grb and SOS would inhibit them from binding to the 
receptor tyrosine kinase dimer through a negative feedback loop.  
In another aspect of feedback inhibition, Erk1/2 can also enter the nucleus to phosphorylate 
various transcription factors, such as Elk-1 and AP-1. The transcription factors are then able to bind the 
promotors of dual specificity phosphatase 1 (DUSP1) and dual specificity phosphatase 6 (DUSP6) which 
act as negative feedback regulators. The DUSPs can directly dephosphorylate Erk1/2 in the cytosol, or 
inhibit phosphorylation of transcription factors by Erk1/2 in the nucleus. In the M3KO EBs, the 
continuous dephosphorization of Erk1/2 may cause the down-regulation of genes that are necessary for 
ES differentiation. Additionally, the over-expression of the DUSPs could cause not only the de-
phosphorylation of Erk1/2, but other MAP Kinase pathways as well, such as the p38. The p38 MAP 
Kinase pathway is also known to regulate OPC development into oligodendrocytes (Chew et al., 2010). 
The de-phosphorylation of this pathway by DUSP6 may possibly inhibit ES differentiation and may inhibit 
the M3KO EBs from progressing into the OPC lineage.  
Conversely, the over-activation of ERK1/2 by calcium-dependent kinases may also cause Erk1/2 
to phosphorylate transcription factors it does not normally act upon, under different cellular contexts. 
This, in turn, may cause the transcription of genes outside of its normal cell-type, including genes that 
inhibit differentiation. The activation of these various genes may explain the significant downregulation 
of the M3KO ES signatures (Figure 2d). 
In normal ESCs, Nanog is part of the feedback loop with Oct4 and Sox2 to regulate proliferation 
and self-renewal. The ES marker, Nanog, was significantly upregulated in the WT EBs treated with FGF 
compared to the untreated WT EBs (Figure 2a). Although this result may be an anomaly, it suggests that 
FGF promotes proliferation in the WT EBs as well as differentiation. We expected Nanog to be down-
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regulated in the FGF supplemented WT EBs due to the differentiation we observed from the WT EBs in 
vitro. Nanog was possibly up-regulated in the WT EBs treated with FGF because both the EBs and their 
differentiating cells were included together in the ΔΔCT calculations. This indicates that FGF may be 
serving two functions at once. Since the majority of the cells were undifferentiated and still packed 
together inside of the EBs, the significant up-regulation of Nanog may indicate that FGF regulates the 
proliferation of the undifferentiated cells within the WT EBs as well as the differentiation stemming 
from the EB surface. There seems to be no difference in the expression of Nanog between FGF treated 
and untreated M3KO EBs (Figure 2c). This may show that, unlike the WT, the addition of FGF neither 
promotes proliferation nor differentiation in the M3KO EBs.  
Pax6, NG2, and Olig2 were all upregulated in the WT with FGF treatment (Figure 2b). However, 
the significant upregulation of Olig2, a glial marker for oligodendrocytes, in the FGF supplemented WT 
EBs suggest that the EBs were differentiating and beginning to express OPC morphology. Due to Pax6 
being a general CNS marker, its significant upregulation in the WTs compared to the M3KOs indicates 
that the WT EBs were beginning to develop a neuronal phenotype but were still plastic enough that cell 
fate was not yet decided. This may be due to the additions of retinoic acid and purmorphamine 
promoting neural crest and neural progenitor formation. The differentiating cells still had the choice to 
mature into neurons or oligodendrocytes. The significant upregulation in WT EBs compared to M3KO 
EBs for NG2 suggests that the FGF supplementation in the WT induced cell commitment to differentiate 
into OPCs. The non-detection of MBP in the WT EBs suggests that the EBs were OPCs and do not have an 
oligodendrocyte morphology.  
We hypothesized that FGF supplementation would have no effect on the M3KO EBs due to an 
inhibition of signaling in the growth factor receptor pathway. However, we found that Pax6 was 
downregulated in the FGF supplemented M3KO EBs (Figure 2d). When compared to WT expression 
levels, both NG2 and MBP glial markers were significantly downregulated in the M3KO EBs with FGF 
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treatment as well. This suggests that the M3KO EBs with FGF supplementation are not differentiating 
since the down-regulation of Pax6, NG2, and Olig2 indicate that they do not express an OPC morphology 
or phenotype. These results may signify that knock-down of golli-MBP, and the subsequent irregular 
Ca2+ signaling, may have an effect on the developmental dysregulation from M3KO ESCs into EBs, 
through the mechanisms mentioned previously. 
Initially, we planned to use ESCs in order generate a pure culture of OPCs to implant into mice 
with traumatic spinal cord injuries. We hoped to use our M3KO mouse model, in this study, to 
investigate the effects of the knock-down of golli-MBP on Ca2+ in vivo. We were not able to accomplish 
this since the unforeseen side-effects of the golli-MBP knock-down resulted in the inability of the M3KO 
EBs to differentiate into OPCs (Figure 1), likely due to the dysregulation of SOCCs and VOCCs in the 
M3KO ESCs. The possibilities are that the elevation of Ca2+ levels in the cytosol may lead to the 
continuous phosphorylation of the MAP Kinase cascade, specifically Erk1/2. This in turn may lead to the 
up-regulation of unexpected differentiation inhibitory genes as well as the genes that are necessary for 
the typical differentiation program. The constant Erk1/2 activation may also cause the over-expression 
of DUSP1 and DUSP6 to not only de-phosphorylate Erk1/2, but de-phosphorylate other MAP Kinases, 
such as p38, as well. Previous studies have shown that golli-MBP is a vital component of VOCCs and 
SOCCs, and Ca2+ is central for many cell processes. Our data indicates that Ca2+ dysregulation due to the 
knock-down of golli-MBP negatively effects the proliferation, migration, and differentiation of ES cells 
into oligodendrocyte progenitor cells. 
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